Low Sodium Oxybate for Idiopathic Hypersomnia
This study is looking at how a medicine called Low Sodium Oxybate affects people with Idiopathic Hypersomnia (IH). IH is a condition where you feel very sleepy during the day, even after a long night's sleep. Low Sodium Oxybate is already approved by the FDA for IH. Researchers want to understand how this medicine changes how long people with IH sleep. They will also use new tools, like special earbuds and a wristband, to track when you are awake or asleep. You may be able to join if you are 18-65 years old, have an IH diagnosis, and usually sleep 9 or more hours a day, including naps. The main goal is to see how your total sleep time changes after 3 months on the medication.
- Study design
- This is an interventional study with 30 planned participants. The phase is not specified, and the status is unclear.
- What's involved
- You would take Low Sodium Oxybate, which will be adjusted to find the right dose, and continue on that dose for 3 months. You will have a 24-hour sleep study (polysomnography), wear special earbuds for 24 hours, and wear a wristband for about one month.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your total sleep time will be measured at the beginning of the study and again after 3 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Low Sodium Oxybate in Patients With Idiopathic Hypersomnia
At a glance
Conditions
Where it's being run
4 sites across 4 statesStudy leadership
- Chad Ruoff, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in Total Sleep TimeBaseline, 3 months
Measured by the 24-hour polysomnography reported as total minutes a participant is deemed sleeping.